Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Oncology & Cancer

An IUD could ward off endometrial cancer in women at risk

For some patients who have early endometrial cancer or a precancerous condition, a hysterectomy may not be a good option because of serious health issues or the desire to preserve fertility.

Oncology & Cancer

IUD saving fertility for women with cancer

A common intrauterine device (IUD) could help preserve fertility and reduce the need for hysterectomies for women suffering endometrial cancer, according to University of Queensland research.

Oncology & Cancer

Every pregnancy helps reduce endometrial cancer risk

New QIMR Berghofer research has found each additional pregnancy a woman experiences, including those that result in miscarriage, can help reduce her risk of developing endometrial cancer.

Oncology & Cancer

Q&A: Understanding endometrial cancer

DEAR MAYO CLINIC: My 54-year-old sister was diagnosed recently with early stage endometrial cancer. She only went to the doctor because she had bleeding between menstrual cycles. I'm wondering if I am at risk, too, and if ...

Oncology & Cancer

Obesity increases endometrial cancer risk

Endometrial cancer, which begins in the uterus within the layer of cells that form the uterine lining, has been on the rise over the past decade. Each year in the U.S., over 60,000 women are diagnosed with endometrial cancer, ...

Obstetrics & gynaecology

NAMS updates guidance for genitourinary syndrome of menopause

(HealthDay)—In a position statement from the North American Menopause Society (NAMS), published in the September issue of Menopause, updated recommendations are presented for the treatment of genitourinary syndrome of menopause ...

page 7 from 17